Malignant melanoma
sistemic chemotherapy
Keywords:
melanomaAbstract
Systemic chemotherapy has shown to be of little usefulness in the treatment of malignant melanoma. Its use has been confined to cases of disseminated
disease. Many drugs have been tried, but objetive remissions have been scarce. The best drug until the present time has been DTIC or imidazole-carboxamide.
In our hands it is given at a dosis of 200 mgm per square meter, five days in a row. Clinical investigations are being performed on prophylactic chemotherapy in patients with positive ly..!Ilph nodes. Prophylactic immunotherapy is also studied in the same type of patients. These investigations are sponsored by the W.H.0. Time is needed to appraise the results of these experiences.
Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
License
All articles, videos and images published in Revista Cirugía del Uruguay are under the Creative Commons CC licenses, which is a complement to the traditional copyright, in the following terms: first, the authorship of the referred document must always be acknowledged and secondly none of the article or work published in the journal may have commercial purposes of any nature. The authors retain their copyrights and give the magazine the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License license that allows the work to be shared whenever the initial publication is indicated in this journal.
